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Role of CCL17 in the Generation of Cutaneous
Inflammatory Reactions in Hu-PBMC-SCID Mice
Grafted with Human Skin
Jules Gilet1,4, Ying Chang1,2,4, Ce´cile Chenivesse1,3, Benjamin Legendre1, Han Vorng1, Catherine Duez1,
Benoıˆt Wallaert1,3, Henri Porte3, Ste´phanie Senechal1 and Anne Tsicopoulos1,3
CCL17 may be of interest in skin inflammation, because it mainly attracts T cells expressing the cutaneous homing
receptor and binds the chemokine receptor CCR4, preferentially expressed on Th-2 cells. We evaluated the in vivo
effect of CCL17 injection in a humanized mouse model. 125I-CCL17 injection into human skin grafted on severe
combined immunodeficient (SCID) mice reconstituted with peripheral blood mononuclear cells resulted in a rapid
transportation of CCL17 from the skin to the homolateral lymph nodes, followed 3hours later by a lymph node
infiltration of human memory CD4þ cells and dendritic cells. Intradermal injection of CCL17 resulted 24hours later
in a cutaneous recruitment of human memory CD4þ cells, monocytes, and basophils, but also murine eosinophils.
In SCID mice reconstituted with polarized Th-1 or Th-2 cells, intradermal injection of CCL17 resulted in the
recruitment of IL-4þ Th-2 cells but not of IFN-gþ Th-1 cells, whereas CCL17 was able to recruit both subsets in vitro.
These results suggest that, in a humanized in vivo model, CCL17 is sufficient per se to induce a lymph node
recruitment of memory CD4þ and dendritic cells and a cutaneous recruitment of Th-2-type cells, stressing it as an
important actor in the initiation and development of Th-2-associated skin inflammation.
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INTRODUCTION
The recruitment of effector cells is an important step in the
development of an inflammatory response, and is orche-
strated in part by chemokines, a group of potent chemotactic
molecules. Chemokines and their receptors are believed to
be essential for leukocyte trafficking from the circulation into
inflammatory tissues. They constitute a large family of low
molecular mass (8–12 kDa) proteins (Baggiolini, 1998; Viola
et al., 2006). Conserved cysteine residues approximately
spaced are the hallmarks of the two major subfamilies of
chemokines, namely CXC and CC. Two other chemokine
molecules, lymphotactin and fractalkine show distinctive
structural characteristics and are, respectively, single mem-
bers of the C and CX3C subfamilies. Chemokines are involved
in a number of inflammatory disorders and in particular in
allergy. This disorder involves the recruitment and activation
of many inflammatory cells, in particular eosinophils,
basophils, and CD4þ lymphocytes, expressing a type 2
cytokine profile (IL-4, IL-5; Robinson et al., 1992). Some
chemokine receptors have been shown to be preferentially
expressed on these three cell types and may represent a
common pathway leading to the development of the allergic
reaction. These receptors and their ligands may represent
good therapeutical targets in allergic reactions. Among them,
CCR4 has been shown to be expressed on type 2 lymphocytes
(Sallusto et al., 1998; Imai et al., 1999), and basophils (Power
et al., 1995), and one of its ligand, the CC chemokine,
CCL17/thymus and activation-regulated chemokine (Imai
et al., 1997, 1999), may be of interest in cutaneous allergic
inflammatory disorders. CCL17 is produced by activated
endothelial cells (Campbell et al., 1999), as well as by
keratinocytes in the basal epidermis in atopic dermatitis
(Vestergaard et al., 2000). CCL17 is expressed in vitro by
keratinocytes stimulated with tumor necrosis factor-a, IFN-g
or IL-1b. Moreover, CCL17 attracts mainly CD4þ T cells,
which express the skin homing receptor cutaneous lympho-
cyte-associated antigen (CLA; Campbell et al., 1999) and
binds CCR4, which under physiological conditions is a
nonredundant necessary component of skin-specific lympho-
cyte trafficking (Campbell et al., 2007). Recently, CCL17
expression has been shown to be increased in different skin
allergic diseases in humans (Vestergaard et al., 2000;
Goebeler et al., 2001; Sebastiani et al., 2002) and to correlate
with the clinical activity of atopic dermatitis (Kakinuma et al.,
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2001; Hijnen et al., 2004; Song et al., 2006). All these data
suggest that CCL17 may be directly involved in Th-2-
associated skin inflammatory reactions. However, most data
are derived from in vitro studies, or from animal models, and
may not reflect accurately the situation in humans. Ethical
considerations have restricted the scope of investigations in
man, therefore the use of humanized models are needed to
fully understand the role of chemokines in inflammatory
reactions. We therefore used the severe combined immuno-
deficient (SCID) mouse, which exhibits a defect in antigen
receptors on the T and B lymphocytes, and can be
reconstituted with a functional human immune system
(Mosier et al., 1988). The model of SCID mice grafted with
skin alone (Yan et al., 1993; Nickoloff et al., 1995) or with
peripheral blood mononuclear cells (PBMCs) has been
previously extensively used in the field of skin diseases
(Juhasz et al., 1993; Gilhar et al., 1997) and to study different
types of T-cell-mediated cutaneous inflammation (Petzel-
bauer et al., 1996; Tsicopoulos et al., 1998; Fahy et al., 2001;
Senechal et al., 2002; de Nadai et al., 2006) and graft
rejection (Murray et al., 1994; Sultan et al., 1997). In this
study, we used the immunodeficient SCID mouse model
grafted with human skin and reconstituted with autologous
PBMC to evaluate in vivo the role of cutaneous CCL17 in the
generation of inflammatory reactions.
RESULTS
CCL17 accumulates in human skin and in draining lymph nodes
after intradermal injection into human skin xenografts
To test whether the chemokine could be transported by
afferent lymph in animals, we injected 125I-CCL17 intrader-
mally into one skin graft, and the diluent into the contralateral
skin graft of each mouse. The distribution of 125I-CCL17 was
evaluated in the homo and contralateral lymph node (LN)
and in different organs 15, 60, and 120 minutes after
intradermal injection. A strong signal was detected in the
homolateral skin draining LN, as soon as 15 minutes after
intradermal injection of CCL17 as compared with the
contralateral LN (Figure 1a). The signal in the homolateral
skin draining LN was maximal at 60 minutes and remained
elevated 120 minutes after injection (Figure 1b and c). A
small signal was also observed in the contralateral LN at 60
and 120 minutes showing that some CCL17 may recirculate
to the other side. A strong signal was evidenced at all time
points in the CCL17-injected skin. Only background levels of
125I-CCL17 were observed whatever the time point in the
spleen, thymus, and liver. A nonsignificant increase appeared
in the contralateral kidney at 120 minutes probably reflecting
the route of CCL17 clearance. In the peripheral blood, the
signal remained low with time, without diffusion in the
systemic circulation. These results show that in human skin,
intradermally injected CCL17 is distributed to the draining LN.
CCL17 injection into human skin xenografts from humanized
SCID mice induces a recruitment of memory T cells in draining
peripheral lymph nodes
Given the strong transportation of CCL17 to the superficial
draining LN, we examined the potential recruitment of
human cells in LN, kinetically after intradermal injection of
CCL17 as compared with the contralateral diluent-injected
site using immunohistochemistry. Given the small accumula-
tion of CCL17 in the contralateral LN, experiments were
performed to check the presence of human cells at baseline
after intradermal injection of diluent in the two skin grafts of a
given mouse (called diluent/diluent). Human cells mainly T
cells and some dendritic cells (DCs) were observed in LN
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Figure 1. Kinetics and distribution of intradermally injected human
125I-CCL17. 125I-CCL17 was injected intradermally into one skin graft
(homolateral) and the control diluent into the contralateral skin graft of each
mouse. Radioactivity was evaluated 15, 60, and 120 minutes after injection in
skin, skin draining homolateral and contralateral LN, kidney, mesenteric LN,
spleen, liver, and blood. Tissues were weighed and counted on a g-counter.
The specific radioactivity associated with each organ was expressed per unit
wet weight as the mean c.p.m.±SEM for n¼ 4–6 per time point. *Po0.05.
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draining diluent/diluent-injected skin, showing that there was
a spontaneous recirculation of cells following diluent
injection in this model (Figure 2a and b). In mice injected
with both diluent and CCL17, a significant infiltration of
human CD45þ cells mostly constituted by CD4þ cells was
observed in the LN draining CCL17-injected skin, as
compared with the control diluent-injected site, starting at
3 hours after CCL17 injection, until 24 hours (Figure 2a). For
the time points before 3 hours and after 24 hours (namely
30 minutes, 1 hour and 30 minutes, and 48 hours after CCL17
injection) no significant cell recruitment was observed as
compared with the control. Only memory CD45ROþ cells
(Figure 7a) but not CD45RAþ cells (data not shown) were
differentially recruited to the LN following CCL17 injection.
Cells expressing CCR4 were recruited in the LN draining
CCL17-injected skin, and were significantly higher than in
the LN draining the control site. However, these cells
represented only one half of the recruited CD4þ cells (Figure
2b). In the contralateral LN, the number of recruited T cells at
3 and 6 hours was higher than in the LN from diluent/diluent
mice. There was no recruitment of the CD8þ T-cell
subpopulation (data not shown). Concerning DCs, no
immature CD1aþ cell recruitment was observed. For DC-
lysosomal-associated membrane proteinþ mature DCs, there
was increased recruitment 3 hours after injection in both LN
draining CCL17- and diluent-injected sites as compared to
the diluent/diluent mice (Figure 2b). Other studies have
shown that eosinophils and mast cells are also found in LN
(Wang et al., 1998; Shi et al., 2000), however, no mast cell,
basophil, eosinophil, and B-cell infiltration was observed in
the LN in our study, whatever the time point (data not
shown). To check the specificity of CCL17-induced recruit-
ment, experiments were performed with intradermal injec-
tions of the same amount of CCL17 mixed with neutralizing
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Figure 2. Kinetics of cell recruitment in draining LN. Mice were reconstituted i.p. with autologous PBMC and CCL17 or the diluent were immediately injected
into human skin xenografts. (a) Kinetics of T-cell recruitment in LN draining CCL17- versus diluent-injected sites, draining diluent/diluent-injected mice, or
draining CCL17/anti-CCL17-injected sites. Cryostat sections of the draining LN were immunostained with monoclonal antibodies against CD45þ leukocytes,
CD4þ T cells, CD45ROþ memory T cells. Results are expressed as the mean number±SEM of positive cells per lymph node section for n¼6–8 mice per time
point. *Po0.05. **Po0.01. (b) Kinetics of CCR4þ cell and DC recruitment in LN draining CCL17- versus diluent-injected sites, draining diluent/diluent-injected
mice, or draining CCL17/anti-CCL17-injected sites. Immature DC were assessed using the CD1a antibody, mature DC using the DC-LAMP antibody. Results are
expressed as above.
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anti-CCL17 antibody. The number of recruited cells at the
different time points was similar to that observed in the
diluent/diluent mice showing the specificity of the CCL17-
induced recruitment (Figure 2).
CCL17 injection into human skin xenografts from humanized
SCID mice induces a recruitment of cutaneous inflammatory
cells
The human cellular infiltration following CCL17 injection
into skin xenografts obtained from humanized SCID mice
was examined using immunohistochemistry. Kinetics and
dose–response experiments were performed to determine the
optimal time points of action and doses of CCL17. The
maximal effect on cell recruitment was observed at a dose of
2.5 mg CCL17, and the optimal time point was found to be
24 hours (data not shown). There was no significant recruit-
ment at 6 hours and the effect was abolished at 48 and
72 hours. These optimal conditions were selected for the rest
of the study.
A significant infiltration of human CD45þ leukocytes was
observed at the site of CCL17 injection as compared with the
diluent (Figure 3a). Among the T-lymphocyte population,
only the CD4þ subpopulation significantly increased after
CCL17 injection (Figure 7b and c) whereas the CD8þ
subpopulation remained stable. Memory and naı¨ve T cells
as assessed by the surface markers CD45RO and CD45RA
were both recruited following CCL17 injection as compared
with the diluent whereas CD25þ cells were not recruited.
Among the other cell types, small numbers of basophils and
CD68þ monocytes/macrophages were also recruited after
CCL17 injection as compared to the diluent (Figure 3b). No
human eosinophils were present in this model, because mice
were reconstituted with PBMC only. However, we were able
to detect a small recruitment of murine eosinophils (as
assessed by the antimurine major basic protein antibody)
following CCL17 injection. CCL17 injection had no signifi-
cant effect on the number of HLA-DRþ cells (data not
shown).
To check the specificity of CCL17-induced cutaneous cell
recruitment, CCL17 was coadministered intradermally with
neutralizing anti-CCL17 antibody at a dose able to comple-
tely inhibit CCL17 dependent chemotaxis in vitro, and skin
biopsies were performed 24 hours later. As observed in LNs,
there was no cutaneous leucocyte recruitment 24 hours after
this coinjection (data not shown).
Distribution of CLAþ and CCR4þ cells in circulating blood and
skin in humanized SCID mice
The distribution of cells expressing the cutaneous homing
receptor CLA, and CCR4 was compared between peripheral
blood (by flow cytometry) and skin (by immunohistochem-
istry). Six hours after reconstitution, 9.3±3.9% (mean±SEM,
n¼4) of blood CD4þ cells expressed CLA, and 25.8±2.5%
expressed CCR4, which was not very different from the
prereconstitution levels (16.9±1.2 CD4þCLAþ and
19.2±1.7% CD4þCCR4þ ). In the skin, 24 hours after
reconstitution and CCL17 injection, the mean number of
CLAþ cells represented 50.6±4.3% of CD4þ cells, and the
number of CCR4þ cells 46.5±2.5% of CD4þ cells showing
an enrichment compared to the blood (data not shown).
CCL17 preferentially recruits Th-2 cells in human skin
xenografts from humanized SCID mice
CCL17 has been shown to preferentially chemoattract Th-2
lymphocytes in vitro (Imai et al., 1999). Less is known about
its potential in vivo, in humans. Therefore, we used our
humanized model to assess CCL17 capacity to chemoattract
human Th-1 or Th-2 cells in vivo. Autologous T cells from the
skin donor were polarized in vitro towards Th-1 or Th-2 cells
using cytokine cocktails. The generated subsets were well
polarized, as assessed by the mean percentage of cytokine
secreting cells (Th-1 cells: 73.6±11.2% of IFN-gþ cells and
5.9±2.1% of IL-4þ cells; Th-2 cells: 65.8±5.3% of IL-4þ
cells and 22.9±7.6% of IFN-gþ cells, mean±SEM of n¼ 3),
both expressed CCR4 although at a higher level on Th-2 cells
than on Th-1 cells (Th-2 cells: 53.6±3.7%; Th-1 cells:
37.7±7.5%), and presented a similar degree of apoptosis
(Th-2 cells: 26.8±6.3%; Th-1 cells: 31.6±2.3%). A repre-
sentative example is shown in Figure 4. When SCID mice
were reconstituted with Th-1 cells, there was no significant
effect of intradermal CCL17 injection on the recruitment of
CD4 positive cells, whereas after Th-2 cell reconstitution, a
significant infiltration of human CD4 positive cells was
observed at the site of CCL17 injection as compared with the
diluent (Figure 5a). CCL17 injection induced in Th-2
reconstituted SCID mice, an increase in CCR4þ cell
recruitment, as compared with the diluent control, whereas
no significant effect was observed in Th-1 reconstituted SCID
mice (Figure 5a).
To ascertain the cytokine profile of the recruited T helper
cells, the production of IFN-g (type 1 cytokine) and IL-4 (type
2 cytokine) was evaluated by immunohistochemistry in
human skin xenografts. In Th-2 reconstituted SCID mice,
CCL17 injection induced an increase in IL-4 producing cells
(Figure 7d) as compared with the diluent control, whereas no
effect was observed for IFN-g producing cells. In Th-1
reconstituted mice, CCL17 did not recruit either IL-4 or
IFN-g producing cells (Figure 5a).
To understand why Th-1 cells were not recruited to the
skin xenografts, LNs draining the injected skin collected at
the same time as the skin, that is 24 hours after reconstitution
and cutaneous injections, were examined. In Th-2 recon-
stituted SCID mice, almost no IL-4þCD4þ cells were found
in the LNs draining CCL17-injected site as compared with the
diluent-injected site, whereas in Th-1 reconstituted SCID
mice, no difference in the number of IFN-gþCD4þ cells was
observed between the LNs draining the diluent and CCL17-
injected sites (Figure 5b). This absence of redistribution was
not related to a loss of CCR4 expression, as almost all LN Th-
1 cells expressed CCR4 (Figure 5b).
Chemoattractant effect of CCL17 in vitro
The above results show that in our in vivo model, cutaneous
injection of CCL17 was clearly associated with a human
leukocyte infiltration consisting in Th-2 cells, naı¨ve T cells,
monocytes, basophils, and also murine eosinophils. This can
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result from a direct chemoattractant effect through CCR4 or
an indirect effect mediated through other cells present in the
skin. CCR4 has been convincingly shown to be expressed on
Th-2 memory cells (Imai et al., 1999; Yamamoto et al., 2000;
Sebastiani et al., 2002) but its expression on the other cell
types cited above remains controversial. To investigate these
possibilities, we performed a direct chemotaxis assay with
polarized Th-2 and Th-1 cells, naı¨ve T cells, monocytes,
basophils, and murine eosinophils. The results showed that
in vitro, polarized Th-2 cells were attracted by CCL17 but
also Th-1 cells although at a dose 10-fold higher than that
necessary for Th-2 cell recruitment. CCL17, in vitro, did not
attract CD45RAþ naı¨ve T cells (Figure 6a). CCL17 was also
able to attract monocytes, murine eosinophils, and to a lesser
extent human basophils (Figure 6b).
DISCUSSION
In the past years, there has been growing interest in
chemokines and their receptors as potential therapeutical
targets in different diseases and in particular in allergic
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Figure 3. Human cell cutaneous recruitment in skin xenografts from humanized SCID mice 24hours after i.d. CCL17 versus diluent injections. (a)
Characterization of the T-cell infiltrate. CCL17 was injected into human skin xenografts immediately after i.p. reconstitution with autologous PBMC. Cryostat
sections of human skin biopsies were immunostained with monoclonal antibodies against CD45þ leukocytes, CD4þ and CD8þ T-cell subpopulations,
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Results are expressed as above.
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diseases such as atopic dermatitis (Johnson et al., 2005).
Mutated antagonists are currently being developed that
appear species specific, arguing for the necessity of in vivo
humanized animal models. The model of SCID mice grafted
with human skin appeared to be particularly suited to CCL17,
given its particular effect on the recruitment of CLAþ cells
(Campbell et al., 1999; Vestergaard et al., 2000; Ferenczi
et al., 2002) and its increased expression in different skin
allergic disorders (Vestergaard et al., 2000; Goebeler et al.,
2001; Wenzel et al., 2005).
CCL17 is known to be constitutively expressed in thymus
and LN (Lieberam and Forster, 1999), and to be induced in
some cells under stimulation (Imai et al., 1999), but it is not
known if CCL17 can be transported as a soluble mediator to
LN. This way of transport has been previously described for
only a few chemokines including CCL21 and CCL2 (Stein
et al., 2000; Palframan et al., 2001). Chemokines transported
from skin to the draining LN persist for more than 4 hours
(Stein et al., 2000) allowing the recruitment of specialized
leukocyte subsets. Using 125I-labeled CCL17, our results
demonstrate that in the case of local cutaneous expression of
CCL17, this chemokine can be directly transported to
superficial draining LN, suggesting that it may participate as
a remote control mechanism in the recruitment of cells
involved in the initiation of an inflammatory reaction in LNs.
In this context, it is of interest that CCL17 has been shown to
be released in an IgE-dependent manner by mast cells both in
mice and humans (Oliveira and Lukacs, 2001; Wakahara
et al., 2001). Mast cells might thus represent an early source
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of CCL17 production very early after an IgE-dependent
stimulus. The limited spillover observed after 125I-labeled
CCL17 injection in the contralateral skin draining LNs, led to
a small additional recruitment of T cells as compared to the
diluent/diluent-injected mice, whereas a more important
recruitment of DC was obtained suggesting that the latter
may respond to a smaller amount of CCL17 than T cells.
CCL17 was sufficient on its own to induce the recruitment of
CD4þ memory T cells and DC, but not mast cells and
basophils in the draining LN. In the LN draining CCL17-
injected skin graft, only part of the recruited CD4þ T-cells
expressed the CCL17 receptor CCR4, suggesting either a local
desensitization of CCR4 by CCL17, as already described
in vivo (de Lavareille et al., 2001), or a lack of sensitivity of
the antibody for cells expressing low level of CCR4, or a
recruitment through another receptor than CCR4. Controver-
sial data have been published on CCR8 as a potential other
receptor for CCL17 (Bernardini et al., 1998; Garlisi et al.,
1999).
Kinetics studies showed that memory CD4þ T cells
appeared in the skin only 24 hours after intradermal injection
of CCL17, at which time these cells had almost entirely
disappeared from the LN, suggesting their redistribution from
LN to the skin. Intradermal injection of CCL17 into the skin
xenografts induced a recruitment of human leukocytes
constituted mainly by CD4þ cells, memory and naı¨ve T
cells. This is in agreement with previous in vitro studies
showing CCL17 chemotactic activity on CD4þ cells (Imai
et al., 1996). In contrast, CD8þ cells were not recruited by
CCL17 in human skin xenografts conversely to in vitro
observations with human CD8þ T-cell lines (Sebastiani et al.,
2002). The attraction of memory T cells by CCL17 is well
characterized (Yamamoto et al., 2000; Sebastiani et al.,
2002), whereas naı¨ve T cells are usually unresponsive to
CCL17 (Campbell et al., 1999; Lieberam and Forster, 1999).
One surprising result was thus the attraction of naı¨ve T cells
in our in vivo model, in contrast to the in vitro data and the
known lack of tissue circulation of naı¨ve T cells. One
explanation might be that the CD45RAþ cells recruited in the
skin are not real naı¨ve T cells but terminally differentiated
memory T cells that are CD45RAþ but do not express CCR7
(Saule et al., 2006). Data have suggested that CD4þCD25þ
regulatory T cells preferentially expressed the CCR4 and
CCR8 receptors and were attracted by CCL17 (Iellem et al.,
2001). However, intradermal injection of CCL17 into the
human skin xenografts did not induce significant CD25þ cell
recruitment, suggesting that additional pathways are required
to attract regulatory cells into the skin. Contradictory results
have been published in the literature about the presence
(Power et al., 1995) or absence (Imai et al., 1997) of CCR4 on
monocytes. In our study, CCL17 clearly attracted monocytes
both in vitro and in vivo, strongly suggesting the presence of a
CCL17 specific receptor on monocytes, such as CCR4.
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Figure 6. Direct chemotactic effect of CCL17 on: (a) Human Th-2, Th-1, and
CD45RAþ T cells. (b) Murine eosinophils, human basophils, and monocytes.
Chemotaxis assays were performed using a Boyden chamber, with CCL17 at
different doses and RPMI control. Results are expressed as the mean number
of recruited cells per well for T cells and per field for the other cells.
a b
c d
Figure 7. Microphotographs of immunohistochemistry on cryostat sections.
(a) Skin draining LN 3 hours after CCL17 intradermal injection immunostained
with anti-CD45RO antibody. (b, c) Human skin graft 24 hours after diluent (b)
or CCL17 (c) injection, immunostained with anti-CD4 antibody. (d) IL-4
positive cells in a cryostat section of a human skin graft injected with CCL17
taken from a mouse reconstituted with polarized Th-2 cells. Arrows point out
positive cells. Scale bar¼ 50mm.
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Human basophils were also attracted by CCL17 in human
skin xenografts. Although CCR4 has been cloned from a
human basophilic cell line (Power et al., 1995), we
evidenced no or little CCR4 expression on human basophils
by flow cytometry (data not shown). However, a slight
chemoattractant effect was observed in chemotaxis assays,
suggesting that this effect might be mediated by another
receptor. Such a discrepancy has already been observed for
CCL22, another CCR4 ligand, which appears to contribute to
eosinophil accumulation without acting through CCR4
(Bochner et al., 1999). The recruitment of murine eosinophils
after CCL17 injection into the skin was linked to a cross-
reactivity between the human chemokine and murine
eosinophils as shown in the chemotaxis assay. This cross-
reactivity has also been shown in another study, although the
authors were unable to evidence CCR4 expression on murine
eosinophils (Borchers et al., 2002).
Although CCR4 is preferentially expressed on Th-2 cells
(Bonecchi et al., 1998; D’Ambrosio et al., 1998; Sallusto
et al., 1998; Syrbe et al., 1999), under certain conditions of
stimulation, CCR4 can also be expressed on Th-1 cells
(D’Ambrosio et al., 1998; Andrew et al., 2001). This study
shows that in our in vivo model, CCL17 induced the
recruitment of Th-2 cells but not Th-1 cells to the skin,
which is in contrast with the in vitro chemotaxis assays,
showing that both Th-1 and Th-2 cells were attracted by
CCL17. It is of note that there was no difference of viability or
apoptosis in the generated T helper sub populations, which
might have explained a difference of migration of the two
subsets. Such responsiveness from polarized Th-1 cells may
be explained by the fact that CCR4 expression is induced on
Th-1 cells after anti-CD3 stimulation (D’Ambrosio et al.,
1998), a condition that we used to polarize the cells. Indeed,
CCR4 was expressed on both polarized Th-1 and Th-2 cells,
albeit at a lower level on Th-1 cells in vitro. CCR4 expression
persisted in vivo on both Th-1 and Th-2 cells present in the
LNs, ruling out an absence of Th-1 recruitment related to a
loss of CCR4 expression. Because CCL17 could attract Th-1
cells in vitro, through a simple filter, but not in vivo, these
results suggest that more complex events take place in vivo,
to fine-tune the recruitment of T-cell subpopulations into the
skin, through the endothelium layer. Accordingly, a recent
study has shown that CCL22, through CCR4, was able to
mediate the adhesion of both Th-1 and Th-2 cells on the
endothelial adhesion molecule, VCAM-1, whereas CCL17
was only effective on the adhesion of Th-2 cells (D’Ambrosio
et al., 2002). In a previous study, we also showed using the
same skin grafted SCID model that CCL22 recruited equal
numbers of IL-4 and IFN-g positive cells (Fahy et al., 2001).
Therefore, two distinct ligands binding the same receptor can
recruit selective T-cell subpopulations, depending on addi-
tional costimuli.
Altogether, these data show that an overexpression of
CCL17 in the skin leads to its rapid transportation to the
draining LN, that allows the recruitment of DC and CCR4þ
memory T cells in LN at 3–6 hours, which will be
redistributed to the skin at 24 hours. In addition, it suggests
a fundamental role for CCL17 both in the initiation of an
immune response following antigen encounter with the skin,
and in the development of the cutaneous inflammatory
reaction.
MATERIALS AND METHODS
Reagents
Antihuman CD45, CD25 (IL-2 receptor chain a), and CD4 antibodies
were purchased from Becton Dickinson (San Jose, CA). Antihuman
CD8, CD68 (macrophages), CD1a (DC phenotype), CD45RO
(memory T-cell phenotype), HLA-DR were from Dako (Glostrup,
Denmark), antimurine major basic protein antibody was an in house
rabbit polyclonal antibody, which recognizes specifically murine
esinophil MBP, a kind gift of GJ Gleich (Mayo Clinic, Rochester,
MN; Filley et al., 1981) monoclonal antibody BB1 was used to
specifically stain human basophils and was a kind gift of AF Walls
(Southampton, UK; McEuen et al., 1999). Antihuman DC-lysosomal-
associated membrane protein (mature DC phenotype) was from
Beckman Coulter (Marseille, France), antihuman CCR4 was from
Santa Cruz Biotechnology (Santa Cruz, CA) and antihuman tryptase
(mast cell phenotype) was from Chemicon (Temecula, CA). Antihu-
man CD45RA (naı¨ve T-cell phenotype) and antihuman CD19 (B-cell
phenotype) were from Dako, antihuman IL-4 as well as anti-CLA
antibodies were from Pharmingen (San Diego, CA), and antihuman
IFN-g antibody was from Ibt (Hycult Biotechnology, Uden, the
Netherlands). Fast Red (Fast Red/Naphtol ASMX tablets) was from
Sigma, St Quentin Fallavier, France. For flow cytometry, antihuman
CD4-PECy5, antihuman CCR4-PE, and antihuman CLA-FITC were
from BD Biosciences (San Jose, CA).
Human donors
Skin from human donors was obtained from truncal operation in
which skin was discarded. Skin was kept in sterile normal saline with
added penicillin and streptomycin and transplanted onto SCID mice
within 2 hours after harvesting. Blood from the same donors was
collected on heparin 6 weeks after surgery. The protocol was
approved by the Centre Hospitalier Re´gional et Universitaire ethical
committee (no. 96,102). All donors signed an informed consent form
according to the declaration of Helsinki Principles.
Animals
Inbred mice with severe combined immunodeficiency (CB-17 SCID
mice) were obtained from breeding pairs originally provided by M
Lieberman (Stanford University, Stanford, CA) maintained at the
Institute Pasteur of Lille in sterilized isolators. Leaky mice (displaying
spontaneous IgG production after 6 weeks of age) were discarded.
Mice were housed under pathogen-free conditions. Animals were
handled according to the ethical principles of animal experimenta-
tion established by the European Center of Tufts University.
Skin grafting
Skin grafting was performed as described by Yan et al. (1993). After
anesthesia, 6 to 8-week-old mice were prepared for grafting by
shaving the hair from a 5-cm2 area on each side of the lateral
abdominal region. Two circular graft beds, approximately 1.5 cm
diameter, were prepared by removing shaved murine skin. Full
thickness human skin grafts of the same size were placed onto
wound beds. The use of two skin grafts per mouse allowed each
mouse to be its own control. The transplants were held in place
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using 6–0 silk suture material and covered with an adhesive wound
dressing and then with a standard bandage. Dressing material and
sutures were removed 10 days after transplantation.
Distribution of intradermally injected 125I-CCL17
To evaluate the fate of intradermal injected CCL17, 61.6 kBq human
125I-CCL17 (NEN Life Science Products Inc., Boston, MA) in 50 ml
phosphate-buffered saline (PBS) was injected intradermally. Mice
were killed 15, 60, and 120 minutes after injection. The skin draining
and contralateral brachial and inguinal LNs, skin, kidney, mesenteric
LN, spleen, liver were removed and mice were bled. Tissues were
weighed, homogenized, agitated overnight on a shaker with 2 N NaOH
and 0.5% SDS and counted in a g-counter. The specific radioactivity
associated with each organ was expressed per unit wet weight.
Cell isolation
Human PBMC. PBMCs were prepared from blood collected on
heparin. Platelet rich plasma was obtained after centrifugation
(120 g, 15 minutes) and discarded. Blood cells were then diluted in
RPMI 1640 medium (Life Technologies, Paisley, Scotland; vol/vol)
and layered over a Ficoll-Paque gradient (Pharmacia, Uppsala,
Sweden). After centrifugation (400 g, 30 minutes), PBMCs were
harvested and washed.
Human CD4þCD45RAþ cells. PBMCs were prepared from
blood collected on heparin as described above. Then, human
CD45RAþ cells were purified by negative selection using CD4þ T-cell
isolation kit and CD45RO microbeads (Miltenyi Biotec, Bergisch
Gladbach, Germany), according to the manufacturer’s recommendations.
Murine eosinophils. Murine eosinophils were obtained from
transgenic mice expressing murine IL-5 under the control of the
human CD2 promoter. Briefly, after killing, spleens of animals were
recovered, crushed, resuspended in RPMI and filtered through a
nylon filter (Bultex, Sailly, France). Red blood cells were eliminated
by hypotonic shocks.
Human monocytes. Human monocytes were purified from PBMC
by positive selection using CD14 microbeads (Miltenyi Biotec,
Bergisch Gladbach, Germany), according to the manufacturer’s
recommendations.
Human basophils. Peripheral blood (50 ml) was collected in a
heparinized syringe. Ten milliliters of 6% dextran in Hanks’
balanced salt solution was added to the heparinized blood, and
erythrocytes were allowed to sediment (during 40 minutes at 37 1C).
The buffy layer was then collected and mixed with RPMI-1640
medium (vol/vol) before it was overlaid onto Ficoll-Paque and
centrifuged (1,000 g, 30 minutes). Cells at the medium–Ficoll inter-
face (PBMC containing basophils, as well as lymphocytes and
monocytes) were collected, washed, and enumerated. Then, human
basophils were purified using human basophil isolation kit (Miltenyi
Biotec), according to the manufacturer’s recommendations.
Generation of polarized Th-1/Th-2 cells
T cells from the skin donor were polarized in vitro towards a Th-1 or
a Th-2 cytokine profile as previously described (Asselin et al., 1998;
Imai et al., 1999). CD4þCD45RAþ were activated with coated anti-
CD3 (10 mg ml1; Pharmingen) in the presence of 2 ng ml1 IL-12
(R&D Systems, Abington, UK) and 200 ng ml1 anti-IL-4 (R&D
Systems) for induction of Th-1 cells, or 10 ng ml1 IL-4 (R&D
Systems) and 2mg ml1 anti-IL-12 (R&D Systems) for induction of Th-
2 cells. After 3 days, 10 ng ml1 IL-2 (Tebu, Le Perray en Yvelines,
France) was added to the cultures. At day 10, some cells were
restimulated with coated anti-CD3 (2 mg ml1) and soluble anti-
CD28 (2mg ml1; Pharmingen) during 5 hours. Polarization was
checked by flow cytometry (FACScalibur; BD Biosciences) by
assessing IFN-g and IL-4 secreting cells by using the IFN-g and IL-
4 secretion assay kits (Miltenyi Biotec). Cell apoptosis was
determined by flow cytometry using an annexin V/propidium iodide
apoptosis assay kit (BD Biosciences). Apoptotic cells stained annexin
Vþ PI and dead cells stained annexin VþPIþ . The remaining cells
were used to reconstitute the SCID mice and for chemotaxis assays.
Experimental protocol for lymph node and cutaneous human
cell recruitment
Six weeks after human skin transplantation, antiasialo GM1 (1/20
dilution, Wako, Osaka, Japan) was injected intraperitoneally to
neutralize murine NK activity. Twenty-four hours later, SCID mice
were reconstituted intraperitoneally with 20 106 autologous PBMC
purified from the donor’s blood resuspended in PBS, or with
10 106 autologous polarized Th-1 or Th-2 cells. The use of
mononuclear cells and skin specimens obtained from the same
human donor for each group of mice was of importance in this SCID
mouse model, because it avoided allogenic reactions during the
reconstitution phase. Recombinant human chemokine CCL17
(PeproTech, Rocky Hill, NJ) was then immediately injected
intradermally, with 5% Evans blue dye (Sigma) to mark the site of
injection, the contralateral graft of each mouse was injected with
diluent containing an equivalent amount of BSA and 5% Evans blue
dye to serve as control. In some mice, the two skin grafts were
injected with diluent to check the spontaneous cell recirculation
following diluent injection. In other experiments, CCL17 was
injected concomitantly with a neutralizing anti-CCL17 antibody at
a dose of 35 mg per injection (R&D Systems) to check the specificity
of the cell recruitment.
For the kinetic study of cell recruitment in peripheral LNs, the
latter were recovered 30 minutes, 1 hour, 1 hour and 30 minutes, 3,
6, 24, and 48 hours after 2.5 mg intradermal CCL17 injection. LN
were fixed in 4% paraformaldehyde and washed in 15% PBS sucrose
before optimum cutting temperature compound embedment, freez-
ing, and storage at 80 1C.
For the cutaneous human cellular recruitment study, human skin
biopsies were performed at the site of injection marked by Evans
blue dye using a cylindrical sterile punch and cut into two halves.
One half was immediately embedded in optimum cutting tempera-
ture compound (Labonord, Villeneuve d’Ascq, France), snap-frozen
in isopentane precooled in liquid nitrogen, and stored at 80 1C. The
other half was fixed in 4% paraformaldehyde, washed in 15% PBS/
sucrose before optimum cutting temperature compound embedding,
freezing, and storage at 80 1C. Preliminary dose responses (0.1, 1,
2.5, 5, and 10 mg diluted in 50ml solvent PBS) and kinetics (6, 24, 48,
and 72 hours) were performed to determine the optimal conditions
for this study. The best cell recruitment in human skin biopsies was
obtained with an intradermal injection of 2.5 mg of CCL17, and at
24 hours.
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Distribution of CD4þCLAþ and CD4þCCR4þ cells in the
peripheral blood of PBMC-reconstituted SCID mice
To evaluate the proportion of circulating CD4þ cells expressing the
CLA and CCR4, SCID mice were reconstituted intraperitoneally with
20 106 PBMC and bled at different time points after reconstitution.
The maximal blood cell recirculation was observed 6 hours after
reconstitution. Blood was collected on heparin coated tubes, red
cells were lysed using the utilyse kit from Dako. Cells were then
double stained with antihuman CD4-PECy5 and antihuman CCR4-
PE or antihuman CLA-FITC, and analyzed by flow cytometry.
Immunohistochemistry
Cryostat sections (6 mm) of unfixed tissues were cut, air dried, fixed in
a mixture of 60% acetone and 40% methanol, dried, wrapped in
aluminum foil and stored at 20 1C for immunohistochemistry. For
all antibodies except antihuman IL-4 antibody, immunochemistry
was performed using a modified alkaline phosphatase antialkaline
phosphatase method as previously described (Tsicopoulos et al.,
2004). Briefly, acetone–methanol fixed cryostat sections were
incubated with the primary antibody for 1 hour, washed in Tris-
buffered saline, and successively incubated 30 minutes with rabbit
antimouse Ig and then monoclonal alkaline phosphatase antialkaline
phosphatase antibodies, both from Dako diluted in 20% normal
human ABþ serum. The coloration was developed using Fast Red
and sections were counterstained using hematoxylin. Irrelevant
primary antibody of the same species was used as negative control.
For IL-4, immunohistochemistry was performed by using a modified
avidine complex method, as previously described (de Nadai et al.,
2006). Briefly, paraformaldehyde-fixed sections were incubated in
0.3% Triton X-100 for 20 minutes and with PBS containing 1%
hydrogen peroxide. Endogenous biotin was quenched by using a
Vector Laboratory kit (Peterborough, UK). Sections were preincu-
bated with rabbit serum and incubated overnight with the anti-IL-4
antibody in PBS containing 0.1% saponin (Sigma). Sections were
treated with the ABC Vectastain Elite kit (Vector) and the color
developed by using diaminobenzidine tetrahydrochloride-nickel
(Vector). Substitution of the primary antibody with an irrelevant
antibody of the same species was used as a negative control.
Antihuman antibodies displayed no cross-reactivity with murine
structures, as verified by immunohistochemistry on cryostat sections
from biopsies performed at the border between human and murine
tissue.
Chemotaxis assay
For all cell types evaluated, CCL17 (at a concentration of 108, 107,
and 106 M) as well as control RPMI were used in a 48-well micro
chemotaxis chamber (Neuro Probe, Cabin John, MD) with 5mm pore
polycarbonate filters (Nucleopore Corp, Pleasanton, CA).
Differentiated human Th-1, Th-2, and CD45RAþ cells were
resuspended in RPMI at a concentration of 2 106 cells per ml and
incubated 2 hours at 37 1C in 5% CO2. Cells that had migrated
through the filter were counted in the inferior well, and results were
expressed as mean number of cells per well.
Eosinophils were resuspended at a concentration of 106 cells per
ml and incubated 45 minutes at 37 1C in 5% CO2. Monocytes and
basophils were resuspended at a concentration of 106 cells per ml
and incubated 1 hour and 30 minutes at 37 1C in 5% CO2.
Eosinophils, monocytes, and basophils that had migrated through
the filter were counted under a microscope at a magnification of
 500. Results were expressed as mean number of cells per field.
Each condition was performed in triplicate, and at least four fields
were counted for each well. Chemotaxis was distinguished from
chemokinesis as previously described (Fahy et al., 1999).
Statistical analysis
Slides were encoded and counted in a blinded fashion at  250
magnification using an eyepiece graticule. For skin sections, the
upper edge of the grid was placed at the epidermal junction. For
each specimen, at least three sections were evaluated, from which
three to six fields were counted for immunohistochemistry. Absolute
numbers of positive cells were counted per mm2. For LN, the entire
surface of each section was evaluated, and numbers of positive cells
were counted per LN section. Statistical analysis was performed
using Graph pad software. Results were expressed as mean±SEM.
Comparisons for paired data were performed by using t-test and for
kinetics studies by analysis of variance followed by post hoc test for
multiple comparisons. Values of Pp0.05 were regarded as
statistically significant.
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